Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Neurology|August 19, 2007
How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?M G Brown, S Kirby, C Skedgel, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2009
Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluationP J Veugelers, J D Fisk, M G Brown, et al.Pain|July 1, 1994
Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patientsC J Archibald, P J McGrath, P G Ritvo, et al.Chronic Diseases and Injuries in Canada|July 4, 2014
Performance of administrative case definitions for comorbidity in multiple sclerosis in Manitoba and Nova ScotiaR A Marrie, J D Fisk, K J Stadnyk, et al.British Journal of Obstetrics and Gynaecology|August 1, 1988
Ovarian size in postmenopausal womenR K Goswamy, S Campbell, J P Royston, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 21, 2008
Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelinationA L O Hebb, C S Moore, V Bhan, et al.Neurology|January 21, 2009
Incidence of acquired demyelination of the CNS in Canadian childrenB Banwell, J Kennedy, D Sadovnick, et al.Journal of Neuroimmunology|April 13, 2010
Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosisK C O'Connor, C Lopez-Amaya, D Gagne, et al.Neurogenetics|August 29, 2001
Genetic susceptibility to MS: a second stage analysis in Canadian MS familiesD A Dyment, C J Willer, B Scott, et al.Pageof 2